Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3709754 | 0.88 | L3MBTL1 (0.54) | ALDH1A1L3MBTL1 | |
| SCHEMBL3709752 | 0.88 | L3MBTL1 (0.54) | ALDH1A1L3MBTL1 | |
| SCHEMBL3456030 | 0.84 | HPGD (0.66) | ALDH1A1L3MBTL1 | |
| SCHEMBL13804257 | 0.83 | CNR2 (0.57) | ALDH1A1L3MBTL1 | |
| SCHEMBL13804128 | 0.83 | CNR2 (0.56) | — | |
| SCHEMBL13804245 | 0.83 | CNR2 (0.56) | — | |
| SCHEMBL13804248 | 0.83 | CNR2 (0.56) | — | |
| SCHEMBL20826067 | 0.81 | HPGD (0.55) | L3MBTL1 | |
| SCHEMBL16253009 | 0.81 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1 | |
| SCHEMBL13753554 | 0.80 | HPGD (0.59) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156572-A1 | Nitrogen-containing heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2009-06-18 | — | — | US | disclosed |
| US-20090156572-A1 | Nitrogen-containing heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156572-A1 | Nitrogen-containing heterocyclic compound and use thereof | NTSR2, NTSR1, HNMT | ALDH1A1 2667/4885L3MBTL1 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.